1. Jbara, Amina, Lin, Kuan-Ting, Stossel, Chani, Golan, Talia, Karni, Rotem. 2023. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. In Nature, 617, 147-153. doi:10.1038/s41586-023-05820-3. https://pubmed.ncbi.nlm.nih.gov/36949200/
2. Dou, Xiaoyang, Xiao, Yu, Shen, Chao, Chen, Jianjun, He, Chuan. 2023. RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. In Nature cell biology, 25, 1359-1368. doi:10.1038/s41556-023-01213-w. https://pubmed.ncbi.nlm.nih.gov/37640841/
3. Li, Shangbiao, Chen, Yanwen, Xie, Yuxin, Deng, Fan, Zhou, Aidong. 2023. FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2303561. doi:10.1002/advs.202303561. https://pubmed.ncbi.nlm.nih.gov/37822160/
4. Cao, Jun, Verma, Sunil K, Jaworski, Elizabeth, Routh, Andrew L, Kuyumcu-Martinez, Muge N. . RBFOX2 is critical for maintaining alternative polyadenylation patterns and mitochondrial health in rat myoblasts. In Cell reports, 37, 109910. doi:10.1016/j.celrep.2021.109910. https://pubmed.ncbi.nlm.nih.gov/34731606/
5. Nutter, Curtis A, Jaworski, Elizabeth A, Verma, Sunil K, Yeo, Gene W, Kuyumcu-Martinez, Muge N. 2016. Dysregulation of RBFOX2 Is an Early Event in Cardiac Pathogenesis of Diabetes. In Cell reports, 15, 2200-2213. doi:10.1016/j.celrep.2016.05.002. https://pubmed.ncbi.nlm.nih.gov/27239029/